MRK vs BSX
By Alex · Tickerpine
Merck & Co., Inc. vs Boston Scientific Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | BSX |
|---|---|---|
| Price | $128.66 | $44.23 |
| Market cap | $317.77B | $65.74B |
| P/E ratio | 36.2 | 18.5 |
| ROE | 18.94% | 14.66% |
| Profit margin | 13.59% | 17.29% |
| Revenue growth | 4.90% | 11.60% |
| Dividend yield | 2.64% | — |
| Beta | 0.22 | 0.56 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs BSX in plain English
- MRK is the bigger company — about 4.8× the market cap of BSX.
- BSX is cheaper on earnings (P/E 18.5 vs 36.2).
- MRK earns a higher return on equity (19% vs 15%).
- BSX is growing revenue faster (12% vs 5%).
- MRK pays a dividend (2.64%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
BSX return calculator
See what $1,000 in Boston Scientific Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.